Squarepoint’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-15,756
| Closed | -$47.1K | – | 2732 |
|
2025
Q1 | $47.1K | Sell |
15,756
-34,994
| -69% | -$105K | ﹤0.01% | 2619 |
|
2024
Q4 | $170K | Buy |
50,750
+35,053
| +223% | +$117K | ﹤0.01% | 2427 |
|
2024
Q3 | $52.6K | Buy |
15,697
+1,057
| +7% | +$3.54K | ﹤0.01% | 2432 |
|
2024
Q2 | $48.5K | Sell |
14,640
-5,513
| -27% | -$18.2K | ﹤0.01% | 2366 |
|
2024
Q1 | $81.4K | Buy |
+20,153
| New | +$81.4K | ﹤0.01% | 2277 |
|
2023
Q4 | – | Sell |
-41,308
| Closed | -$124K | – | 2500 |
|
2023
Q3 | $124K | Buy |
41,308
+22,117
| +115% | +$66.4K | ﹤0.01% | 2224 |
|
2023
Q2 | $71.8K | Sell |
19,191
-3,586
| -16% | -$13.4K | ﹤0.01% | 2253 |
|
2023
Q1 | $76.3K | Sell |
22,777
-16,237
| -42% | -$54.4K | ﹤0.01% | 2069 |
|
2022
Q4 | $188K | Buy |
+39,014
| New | +$188K | ﹤0.01% | 1908 |
|
2022
Q1 | – | Sell |
-213,220
| Closed | -$1.91M | – | 2227 |
|
2021
Q4 | $1.91M | Buy |
+213,220
| New | +$1.91M | 0.01% | 897 |
|